Novartis Pharmaceuticals Corporation v. Aurobindo Pharma USA Inc. et al > Summary
Court Case Number 1:21-cv-01407
Filing Date Oct 1, 2021
Termination Date Apr 11, 2023
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesLeonard P. Stark
Plaintiff
Plaintiff Attorneys
6Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Jared L. Stringham
Venable
Defendant Attorneys
8Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma USA
Attorney Name: Steven Jerome Moore
Withersworldwide
Aurobindo Pharma USA
Attorney Name: James E. Nealon
Withersworldwide
Aurobindo Pharma
Attorney Name: R. Touhey Myer
Kratz & Barry
Aurobindo Pharma
Attorney Name: Michael P. Hogan
Kratz & Barry
Aurobindo Pharma
Attorney Name: Timothy H. Kratz
Kratz & Barry
Aurobindo Pharma
Attorney Name: Cortlan S. Hitch
Morris James LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11058667 | Sacubitril-valsartan dosage regimen for treating heart failure | Jul 13, 2021 |
